Q3141961 (Q3141961): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): In bipolar disorder there is a high prevalence of episodes with mixed symptoms. Therefore it is necessary to have an instrument that evaluates clinical symptomatology completely regardless of the characteristics of the episode. Objective: Design a reliable and valid scale to evaluate bipolar disorder in a complete manner, so as to cover the entire spectrum of clinical manifestations present in the bipolar disorder, i.e. episodes of manic and d...) |
||||||||||||||
| Property / summary | |||||||||||||||
In bipolar disorder there is a high prevalence of episodes with mixed symptoms. Therefore it is necessary to have an instrument that evaluates clinical symptomatology completely regardless of the characteristics of the episode. Objective: Design a reliable and valid scale to evaluate bipolar disorder in a complete manner, so as to cover the entire spectrum of clinical manifestations present in the bipolar disorder, i.e. episodes of manic and depressive polarity, as well as associated mixed symptoms. Methodology: The study consists of two phases: the design of the scale and the validation of the scale. During the first phase, the relevant items for the manic and depressive dimensions will be selected. For validation of the scale, patients with bipolar disorder will be recruited according to DSM-5 criteria in a quota sampling to ensure representativeness. Control groups with another psychiatric disorder and general population will be selected to determine the discriminative capacity of the scale. (English) | |||||||||||||||
| Property / summary: In bipolar disorder there is a high prevalence of episodes with mixed symptoms. Therefore it is necessary to have an instrument that evaluates clinical symptomatology completely regardless of the characteristics of the episode. Objective: Design a reliable and valid scale to evaluate bipolar disorder in a complete manner, so as to cover the entire spectrum of clinical manifestations present in the bipolar disorder, i.e. episodes of manic and depressive polarity, as well as associated mixed symptoms. Methodology: The study consists of two phases: the design of the scale and the validation of the scale. During the first phase, the relevant items for the manic and depressive dimensions will be selected. For validation of the scale, patients with bipolar disorder will be recruited according to DSM-5 criteria in a quota sampling to ensure representativeness. Control groups with another psychiatric disorder and general population will be selected to determine the discriminative capacity of the scale. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: In bipolar disorder there is a high prevalence of episodes with mixed symptoms. Therefore it is necessary to have an instrument that evaluates clinical symptomatology completely regardless of the characteristics of the episode. Objective: Design a reliable and valid scale to evaluate bipolar disorder in a complete manner, so as to cover the entire spectrum of clinical manifestations present in the bipolar disorder, i.e. episodes of manic and depressive polarity, as well as associated mixed symptoms. Methodology: The study consists of two phases: the design of the scale and the validation of the scale. During the first phase, the relevant items for the manic and depressive dimensions will be selected. For validation of the scale, patients with bipolar disorder will be recruited according to DSM-5 criteria in a quota sampling to ensure representativeness. Control groups with another psychiatric disorder and general population will be selected to determine the discriminative capacity of the scale. (English) / qualifier | |||||||||||||||
point in time: 12 October 2021
| |||||||||||||||
Revision as of 13:25, 12 October 2021
Project Q3141961 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3141961 in Spain |
Statements
3,250.0 Euro
0 references
6,500.0 Euro
0 references
50.0 percent
0 references
1 January 2017
0 references
31 March 2020
0 references
FUNDACION INVESTIGACION BIOMEDICA HOSPITAL RAMON Y CAJAL
0 references
40°25'0.12"N, 3°42'12.89"W
0 references
28079
0 references
En el trastorno bipolar existe una prevalencia alta de episodios con síntomas mixtos. Por lo tanto es necesario poder contar con un instrumento que evalúe la sintomatología clínica de forma completa independientemente de las características del episodio. Objetivo: Diseñar una escala fiable y válida que permita evaluar el trastorno bipolar de forma completa, de tal forma que cubra todo el espectro de manifestaciones clínicas presentes en el mismo, es decir episodios de polaridad maniaca y depresiva, así como si presentan síntomas mixtos asociados. Metodología: El estudio consta de dos fases: el diseño de la escala y la validación de la escala. Durante la primera fase se seleccionarán los ítems relevantes para las dimensiones maniacas y depresivas. Para la validación de la escala se reclutarán pacientes con trastorno bipolar según criterios DSM-5 en un muestreo por cuotas para asegurar la representatividad. Se seleccionarán grupos control con otro trastorno psiquiátrico y población general para determinar la capacidad discriminativa de la escala. (Spanish)
0 references
In bipolar disorder there is a high prevalence of episodes with mixed symptoms. Therefore it is necessary to have an instrument that evaluates clinical symptomatology completely regardless of the characteristics of the episode. Objective: Design a reliable and valid scale to evaluate bipolar disorder in a complete manner, so as to cover the entire spectrum of clinical manifestations present in the bipolar disorder, i.e. episodes of manic and depressive polarity, as well as associated mixed symptoms. Methodology: The study consists of two phases: the design of the scale and the validation of the scale. During the first phase, the relevant items for the manic and depressive dimensions will be selected. For validation of the scale, patients with bipolar disorder will be recruited according to DSM-5 criteria in a quota sampling to ensure representativeness. Control groups with another psychiatric disorder and general population will be selected to determine the discriminative capacity of the scale. (English)
12 October 2021
0 references
Madrid
0 references
Identifiers
PI16_01319
0 references